ASPEN AEROGELS INC (ASPN) Fundamental Analysis & Valuation

NYSE:ASPN • US04523Y1055

Current stock price

3.06 USD
-0.17 (-5.26%)
At close:
3.07 USD
+0.01 (+0.33%)
After Hours:

This ASPN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ASPN Profitability Analysis

1.1 Basic Checks

  • In the past year ASPN has reported negative net income.
  • In the past year ASPN had a positive cash flow from operations.
  • In the past 5 years ASPN reported 4 times negative net income.
  • In the past 5 years ASPN reported 4 times negative operating cash flow.
ASPN Yearly Net Income VS EBIT VS OCF VS FCFASPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of ASPN (-62.12%) is worse than 97.59% of its industry peers.
  • ASPN has a worse Return On Equity (-99.85%) than 89.16% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.43%, ASPN is doing worse than 61.45% of the companies in the same industry.
Industry RankSector Rank
ROA -62.12%
ROE -99.85%
ROIC 2.43%
ROA(3y)-33.6%
ROA(5y)-26.79%
ROE(3y)-57.54%
ROE(5y)-44%
ROIC(3y)N/A
ROIC(5y)N/A
ASPN Yearly ROA, ROE, ROICASPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • The Operating Margin of ASPN (3.27%) is worse than 61.45% of its industry peers.
  • ASPN's Gross Margin of 32.89% is fine compared to the rest of the industry. ASPN outperforms 66.27% of its industry peers.
  • In the last couple of years the Gross Margin of ASPN has grown nicely.
Industry RankSector Rank
OM 3.27%
PM (TTM) N/A
GM 32.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y82.93%
GM growth 5Y3.11%
ASPN Yearly Profit, Operating, Gross MarginsASPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ASPN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ASPN is destroying value.
  • Compared to 1 year ago, ASPN has more shares outstanding
  • ASPN has more shares outstanding than it did 5 years ago.
  • ASPN has a worse debt/assets ratio than last year.
ASPN Yearly Shares OutstandingASPN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ASPN Yearly Total Debt VS Total AssetsASPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • ASPN has an Altman-Z score of -0.62. This is a bad value and indicates that ASPN is not financially healthy and even has some risk of bankruptcy.
  • ASPN's Altman-Z score of -0.62 is on the low side compared to the rest of the industry. ASPN is outperformed by 86.75% of its industry peers.
  • The Debt to FCF ratio of ASPN is 46.99, which is on the high side as it means it would take ASPN, 46.99 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 46.99, ASPN perfoms like the industry average, outperforming 40.96% of the companies in the same industry.
  • A Debt/Equity ratio of 0.31 indicates that ASPN is not too dependend on debt financing.
  • ASPN's Debt to Equity ratio of 0.31 is fine compared to the rest of the industry. ASPN outperforms 75.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 46.99
Altman-Z -0.62
ROIC/WACC0.29
WACC8.25%
ASPN Yearly LT Debt VS Equity VS FCFASPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • ASPN has a Current Ratio of 3.94. This indicates that ASPN is financially healthy and has no problem in meeting its short term obligations.
  • ASPN has a Current ratio of 3.94. This is amongst the best in the industry. ASPN outperforms 91.57% of its industry peers.
  • A Quick Ratio of 3.33 indicates that ASPN has no problem at all paying its short term obligations.
  • ASPN's Quick ratio of 3.33 is amongst the best of the industry. ASPN outperforms 93.98% of its industry peers.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 3.33
ASPN Yearly Current Assets VS Current LiabilitesASPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ASPN Growth Analysis

3.1 Past

  • ASPN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -223.08%.
  • Looking at the last year, ASPN shows a very negative growth in Revenue. The Revenue has decreased by -40.11% in the last year.
  • The Revenue has been growing by 22.00% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-223.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-378.57%
Revenue 1Y (TTM)-40.11%
Revenue growth 3Y14.54%
Revenue growth 5Y22%
Sales Q2Q%-66.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 49.94% on average over the next years. This is a very strong growth
  • ASPN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.26% yearly.
EPS Next Y3.34%
EPS Next 2Y33.78%
EPS Next 3Y52.26%
EPS Next 5Y49.94%
Revenue Next Year-27.58%
Revenue Next 2Y0.08%
Revenue Next 3Y21.77%
Revenue Next 5Y19.26%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ASPN Yearly Revenue VS EstimatesASPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
ASPN Yearly EPS VS EstimatesASPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

2

4. ASPN Valuation Analysis

4.1 Price/Earnings Ratio

  • ASPN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ASPN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPN Price Earnings VS Forward Price EarningsASPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ASPN indicates a rather cheap valuation: ASPN is cheaper than 86.75% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ASPN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 94.19
EV/EBITDA 7.14
ASPN Per share dataASPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ASPN's earnings are expected to grow with 52.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.78%
EPS Next 3Y52.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ASPN Dividend Analysis

5.1 Amount

  • ASPN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ASPN Fundamentals: All Metrics, Ratios and Statistics

ASPEN AEROGELS INC

NYSE:ASPN (3/20/2026, 8:04:00 PM)

After market: 3.07 +0.01 (+0.33%)

3.06

-0.17 (-5.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners71.67%
Inst Owner Change-0.67%
Ins Owners1.11%
Ins Owner Change1.04%
Market Cap252.91M
Revenue(TTM)271.10M
Net Income(TTM)-305.28M
Analysts76.92
Price Target6.63 (116.67%)
Short Float %10.8%
Short Ratio4.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-101.12%
Min EPS beat(2)-176.85%
Max EPS beat(2)-25.4%
EPS beat(4)2
Avg EPS beat(4)-32.06%
Min EPS beat(4)-176.85%
Max EPS beat(4)57.28%
EPS beat(8)6
Avg EPS beat(8)89.76%
EPS beat(12)10
Avg EPS beat(12)72.04%
EPS beat(16)10
Avg EPS beat(16)45.6%
Revenue beat(2)1
Avg Revenue beat(2)2.56%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)5.47%
Revenue beat(4)1
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-6.73%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)5.37%
Revenue beat(12)7
Avg Revenue beat(12)4.61%
Revenue beat(16)9
Avg Revenue beat(16)3.03%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.26%
EPS NY rev (1m)-58.98%
EPS NY rev (3m)-61.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)-16.73%
Revenue NY rev (3m)-18.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF 94.19
P/OCF 4.82
P/B 0.83
P/tB 0.83
EV/EBITDA 7.14
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)0.03
FCFY1.06%
OCF(TTM)0.63
OCFY20.73%
SpS4.27
BVpS3.7
TBVpS3.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -62.12%
ROE -99.85%
ROCE 2.74%
ROIC 2.43%
ROICexc 3.79%
ROICexgc 3.79%
OM 3.27%
PM (TTM) N/A
GM 32.89%
FCFM 0.76%
ROA(3y)-33.6%
ROA(5y)-26.79%
ROE(3y)-57.54%
ROE(5y)-44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y82.93%
GM growth 5Y3.11%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 46.99
Debt/EBITDA 2.77
Cap/Depr 221.9%
Cap/Sales 14.1%
Interest Coverage 0.81
Cash Conversion 154.39%
Profit Quality N/A
Current Ratio 3.94
Quick Ratio 3.33
Altman-Z -0.62
F-Score4
WACC8.25%
ROIC/WACC0.29
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-223.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-378.57%
EPS Next Y3.34%
EPS Next 2Y33.78%
EPS Next 3Y52.26%
EPS Next 5Y49.94%
Revenue 1Y (TTM)-40.11%
Revenue growth 3Y14.54%
Revenue growth 5Y22%
Sales Q2Q%-66.42%
Revenue Next Year-27.58%
Revenue Next 2Y0.08%
Revenue Next 3Y21.77%
Revenue Next 5Y19.26%
EBIT growth 1Y-73.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.83%
EBIT Next 3Y33.78%
EBIT Next 5Y20.89%
FCF growth 1Y102.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y640.1%
OCF growth 3YN/A
OCF growth 5YN/A

ASPEN AEROGELS INC / ASPN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ASPEN AEROGELS INC?

ChartMill assigns a fundamental rating of 3 / 10 to ASPN.


Can you provide the valuation status for ASPEN AEROGELS INC?

ChartMill assigns a valuation rating of 2 / 10 to ASPEN AEROGELS INC (ASPN). This can be considered as Overvalued.


How profitable is ASPEN AEROGELS INC (ASPN) stock?

ASPEN AEROGELS INC (ASPN) has a profitability rating of 1 / 10.


How financially healthy is ASPEN AEROGELS INC?

The financial health rating of ASPEN AEROGELS INC (ASPN) is 5 / 10.


What is the expected EPS growth for ASPEN AEROGELS INC (ASPN) stock?

The Earnings per Share (EPS) of ASPEN AEROGELS INC (ASPN) is expected to grow by 3.34% in the next year.